Health Catalyst's (HCAT) Still a 'Superior Technology Platform' - Cantor Fitzgerald Nov 11, 2025 07:35AM
Cantor Fitzgerald Reiterates Neutral Rating on Health Catalyst Inc. (HCAT) Sep 9, 2025 08:51AM
Cantor Fitzgerald Downgrades Health Catalyst Inc. (HCAT) to Neutral Aug 8, 2025 02:37AM
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT) Jul 14, 2025 07:03AM
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT) Apr 15, 2025 06:52AM


Apr 1, 2025 07:26AM Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
Aug 1, 2023 06:32AM Cantor Fitzgerald Starts Health Catalyst Inc. (HCAT) at Overweight, 'R&D expense will decline in 2024E and 2025E'
Aug 11, 2021 05:44AM Health Catalyst (HCAT) Prices 4.25M Share Offering at $53/sh
Aug 10, 2021 10:43PM Health Catalyst Announces Pricing of Public Offering of Common Stock
Aug 10, 2021 10:43PM Health Catalyst Announces Pricing of Public Offering of Common Stock
Jun 4, 2020 08:13AM Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT) Following Investor Meetings
Jun 3, 2020 07:23AM Companies with NDRs 6/03
Oct 29, 2019 04:04PM Cantor Fitzgerald Starts Health Catalyst Inc. (HCAT) at Overweight